CULLINAN THERAPEUTICS INC (CGEM)
US2300311063 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -155.10M | 109.20M | -67.49M | -59.46M | -21.65M | |||
| Depreciation Amortization | 310.00K | 90.00K | 50.00K | 60.00K | 70.00K | |||
| Change In Working Capital | -339.00K | 11.18M | -3.54M | 6.85M | 140.00K | |||
| Interest Paid | N/A | 30.00K | N/A | N/A | N/A | |||
| Taxes Paid | 4.43M | 37.80M | N/A | N/A | N/A | |||
| Other non cash items | 20.86M | -247.13M | 27.54M | 22.77M | 550.00K | |||
| OPERATING CASH FLOW | -134.28M | -126.66M | -43.43M | -29.77M | -20.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -208.00K | -1.13M | 0.00 | -10.00K | -20.00K | |||
| Other Investing Activity | 36.01M | 250.11M | -333.78M | -5.41M | -35.38M | |||
| INVESTING CASH FLOW | 35.81M | 248.98M | -333.78M | -5.42M | -35.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.82M | 180.00K | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 38.93M | 6.02M | 270.55M | 139.15M | 84.25M | |||
| Other Financing Activity | 0.00 | -32.13M | -1.77M | 990.00K | 1.47M | |||
| FINANCING CASH FLOW | 40.75M | -25.93M | 268.78M | 140.14M | 85.72M | |||
| CHANGE IN CASH | -57.72M | 96.39M | -108.43M | 104.95M | 29.42M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -134.28M | -126.66M | -43.43M | -29.77M | -20.90M | |||
| Capital Expenditure | -208.00K | -1.13M | 0.00 | -10.00K | -20.00K | |||
| FREE CASH FLOW | -134.48M | -127.79M | -43.43M | -29.78M | -20.92M | |||
All data in USD